Skip to main content
Download PDF

Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction

Echo Research & Practice volume 7, pages M7–M8 (2020)Cite this article

Funding

This work did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

  1. British Heart Foundation Centre, King’s College London, London, UK

    H. Gu PhD, A. Boguslavskyi PhD, G. Carr-White PhD & P. Chowienczyk BSc

  2. Haukeland University Hospital, Bergen, Norway

    S. Saeed PhD

  3. Cardiothoracic Centre, St Thomas’ Hospital, London, UK

    G. Carr-White PhD & J. Chambers MD

Authors
  1. H. Gu PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Saeed PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Boguslavskyi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Carr-White PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Chambers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Chowienczyk BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gu, H., Saeed, S., Boguslavskyi, A. et al. Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction. Echo Res Pract 7, M7–M8 (2020). https://doi.org/10.1007/BF03651754

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03651754

Echo Research & Practice

ISSN: 2055-0464